← Browse by Condition
Medical Condition

coronary arterial disease cad

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for coronary arterial disease cad sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — coronary arterial disease cad Clinical Trials

How many clinical trials are currently recruiting for coronary arterial disease cad?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for coronary arterial disease cad, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary arterial disease cad?
coronary arterial disease cad research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary arterial disease cad clinical trial?
Eligibility criteria for coronary arterial disease cad trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
IRCCS Ospedale San Raffaele 1 trial
CHA University 1 trial
Spanish Society of Cardiology 1 trial
Abcentra 1 trial
TC Erciyes University 1 trial

Recruiting Clinical Trials

NCT07013344
Recruiting
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Enrollment
800 pts
Location
Italy
Sponsor
IRCCS Ospedale San Raffaele
View Trial →
NCT06985693
Recruiting
Medipixel XA-Assisted PCI in Coronary Artery Disease
Enrollment
830 pts
Location
South Korea
Sponsor
CHA University
View Trial →
NCT06736665
Recruiting
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
Enrollment
50 pts
Location
Spain
Sponsor
Spanish Society of Cardiology
View Trial →
NCT06927739 Phase 2
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Enrollment
240 pts
Location
United States, Czech...
Sponsor
Abcentra
View Trial →
NCT06867926
Recruiting
The Effect of Cardiac Rehabilitation on Oxidative DNA Damage and Inflammation in Patients With Coronary Artery Disease
Enrollment
70 pts
Location
Turkey (Türkiye)
Sponsor
TC Erciyes University
View Trial →
NCT06822712
Recruiting
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions
Enrollment
250 pts
Location
China
Sponsor
BrosMed Medical Co., Ltd
View Trial →
NCT07001007
Recruiting
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
Enrollment
1,600 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
View Trial →

Related Conditions

chronic coronary syndrome (2) percutaneous coronary intervention pci (2) chronic coronary total occlusion (1) stable chronic angina (1) nt pro bnp (1) coronary calcification (1) coronary calcified nodules (1) orbital atherectomy (1) intravascular lithotripsy (1) optical coherence tomography oct (1) acute coronary syndrome acs (1) acute coronary syndromes (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology